Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up

Author:

Medved V.1,Kuzman MR2,Jovanovic N.1,Grubisin J.1,Kuzman T.1

Affiliation:

1. Department of Psychiatry, University Hospital Centre Zagreb, Zagreb, Croatia

2. Department of Psychiatry, University Hospital Centre Zagreb, Zagreb, Croatia,

Abstract

The objective of this study was to determine the occurrence of metabolic abnormalities among previously unmedicated female patients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition schizophrenia spectrum disorders and their associations with olanzapine and risperidone treatment. We analysed 94 female patients who were treated with olanzapine or risperidone in the period of 3 months. Analysed variables included fasting glucose, total cholesterol, low-density lipoprotein (LDL), high-density lipoproteins and triglycerides in blood, blood pressure (BP), waist and hip circumferences and body mass index (BMI). At baseline, 14 patients (15%) fulfilled criteria for metabolic syndrome. After 3 months of treatment, 25 patients (27%) fulfilled criteria for metabolic syndrome, and their baseline BMI was the only predictor for its development. Treatment with both antipsychotics was associated with significant increase in waist circumference. Positive family history of diabetes mellitus contributed to a significant greater increase in abdominal obesity, significant higher baseline levels and a borderline significant increase in fasting glucose among olanzapine-treated patients. Olanzapine admission was associated with a significant increase in LDL and risperidone with a significant increase in triglycerides. Metabolic abnormalities seem to be more prevalent in unmedicated female patients with schizophrenia spectrum disorders than expected based on results in general population (adjusted for age and sex). Olanzapine treatment might induce significant alterations in metabolic profiles, especially among patients with positive family history of diabetes, mostly by inducing abdominal obesity. The association of risperidone application and increase in triglyceride level still needs to be determined.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology

Reference30 articles.

1. Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs

2. Serum Leptin and Triglyceride Levels in Patients on Treatment With Atypical Antipsychotics

3. Bierman EL ( 1997) Atherosclerosis and other forms of arteriosclerosis . In Ivancevic Z, Rumbolt Z, Bergovec M, Silobrcic V, Bruketa D: Harrison’s Principles Of Internal Medicine 9th Edition, 1st Croatian edition, eds. XIII, Split, Placebo, pp. 965-973. [ http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf].

4. Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients

5. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3